These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pimecrolimus is effective in Fox-Fordyce disease. Pock L; Svrcková M; Machácková R; Hercogová J Int J Dermatol; 2006 Sep; 45(9):1134-5. PubMed ID: 16961542 [No Abstract] [Full Text] [Related]
6. Fox-Fordyce disease treated with topical clindamycin solution. Miller ML; Harford RR; Yeager JK Arch Dermatol; 1995 Oct; 131(10):1112-3. PubMed ID: 7574824 [No Abstract] [Full Text] [Related]
7. Fox-Fordyce disease in a male patient--response to oral retinoid treatment. Effendy I; Ossowski B; Happle R Clin Exp Dermatol; 1994 Jan; 19(1):67-9. PubMed ID: 8313643 [TBL] [Abstract][Full Text] [Related]
8. Fox-Fordyce disease: a report of 2 cases responding to topical clindamycin. George A; Bhatia A; Thomas E Indian J Dermatol Venereol Leprol; 2015; 81(1):87-8. PubMed ID: 25566917 [No Abstract] [Full Text] [Related]
9. Successful treatment of refractory pruritic Fox-Fordyce disease with botulinum toxin type A. González-Ramos J; Alonso-Pacheco ML; Goiburú-Chenú B; Mayor-Ibarguren A; Herranz-Pinto P Br J Dermatol; 2016 Feb; 174(2):458-9. PubMed ID: 26385128 [No Abstract] [Full Text] [Related]